Debt-to-equity of ENANTA PHARMACEUTICALS INC from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ENANTA PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • ENANTA PHARMACEUTICALS INC Debt-to-equity for the quarter ending 31 Dec 2025 was 239%, a 35% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 239% +62% +35% 31 Dec 2025
Q3 2025 259% +104% +68% 30 Sep 2025
Q2 2025 226% +91% +67% 30 Jun 2025
Q1 2025 200% +78% +64% 31 Mar 2025
Q4 2024 177% +90% +103% 31 Dec 2024
Q3 2024 154% +95% +161% 30 Sep 2024
Q2 2024 135% +99% +268% 30 Jun 2024
Q1 2024 121% +105% +628% 31 Mar 2024
Q4 2023 87% +72% +485% 31 Dec 2023
Q3 2023 59% +45% +304% 30 Sep 2023
Q2 2023 37% +24% +185% 30 Jun 2023
Q1 2023 17% +5.4% +47% 31 Mar 2023
Q4 2022 15% +5.1% +52% 31 Dec 2022
Q3 2022 15% +6.9% +89% 30 Sep 2022
Q2 2022 13% +5.9% +83% 30 Jun 2022
Q1 2022 11% +4.6% +68% 31 Mar 2022
Q4 2021 9.8% +3.5% +55% 31 Dec 2021
Q3 2021 7.8% +1.6% +26% 30 Sep 2021
Q2 2021 7% +1% +17% 30 Jun 2021
Q1 2021 6.7% +0.92% +16% 31 Mar 2021
Q4 2020 6.3% +0.47% +8.1% 31 Dec 2020
Q3 2020 6.2% +0.24% +4.1% 30 Sep 2020
Q2 2020 6% +0.21% +3.7% 30 Jun 2020
Q1 2020 5.8% +0.14% +2.5% 31 Mar 2020
Q4 2019 5.8% +0.07% +1.2% 31 Dec 2019
Q3 2019 6% +0.03% +0.56% 30 Sep 2019
Q2 2019 5.8% -0.88% -13% 30 Jun 2019
Q1 2019 5.7% -1.3% -19% 31 Mar 2019
Q4 2018 5.8% -0.87% -13% 31 Dec 2018
Q3 2018 5.9% +0.16% +2.8% 30 Sep 2018
Q2 2018 6.7% +2% +43% 30 Jun 2018
Q1 2018 7% +2.5% +57% 31 Mar 2018
Q4 2017 6.6% +2% +43% 31 Dec 2017
Q3 2017 5.8% +0.75% +15% 30 Sep 2017
Q2 2017 4.6% -0.38% -7.6% 30 Jun 2017
Q1 2017 4.4% -0.47% -9.6% 31 Mar 2017
Q4 2016 4.6% -1.2% -20% 31 Dec 2016
Q3 2016 5% -2.1% -30% 30 Sep 2016
Q2 2016 5% -2.5% -33% 30 Jun 2016
Q1 2016 4.9% -3% -38% 31 Mar 2016
Q4 2015 5.8% -1.2% -17% 31 Dec 2015
Q3 2015 7.1% +2.3% +47% 30 Sep 2015
Q2 2015 7.5% +2.4% +45% 30 Jun 2015
Q1 2015 7.9% +2.6% +48% 31 Mar 2015
Q4 2014 7% +1.7% +33% 31 Dec 2014
Q3 2014 4.8% 30 Sep 2014
Q2 2014 5.2% 30 Jun 2014
Q1 2014 5.3% 31 Mar 2014
Q4 2013 5.3% 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.